Our team

Hexagon Bio’s diverse team combines computational biology and experimental investigation, with deep expertise at the intersection of these fields.


Maureen Hillenmeyer, PhD

CEO & Founder

Maureen is a founder and CEO of Hexagon Bio. Previously, she was director of the Genomes to Natural Products program and group leader at the Stanford Technology Genome Center.

Brian Naughton, PhD

Head of Data & Founder

Brian is a founder and head of data at Hexagon. Previously, he was founding scientist at 23andMe.

Yi Tang, PhD


Yi is a founder of Hexagon Bio, Professor at UCLA, and a world expert on fungal enzymes and natural products.

Colin Harvey, PhD

Head of Biology & Chemistry & Founder

Colin is a founder and Head of Chemistry and Biology at Hexagon Bio. Previously, he led synthetic biology efforts for natural product discovery at the Stanford Genome Technology Center.

Andy Aymeloglu

Head of Engineering

Andy is the Head of Engineering at Hexagon Bio. Previously he was Director of Engineering at Palantir Technologies.

→ Meet our team on LinkedIn.


Christopher Walsh, PhD

Adjunct Professor, Chemistry, Stanford University

Leonard Post, PhD

Chief Scientific Officer, Vivace Therapeutics

Andrew Perlman, MD PhD

Managing Director & Chief Medical Officer, Velocity Pharmaceutical Development

Julia Hong

Angel Investor & Biotech Advisor

Ram Shriram

Founder, Sherpalo Ventures

Marnix Medema, PhD

Assistant Professor, Bioinformatics, Wageningen University


Hexagon Bio

1505 Adams Drive, Suite A
Menlo Park, CA 94025